Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not always need to pinch the skin for Wegovy, but doing so is recommended if you have less subcutaneous fat at your chosen injection site. The Wegovy pen delivers semaglutide into the fatty layer just beneath the skin; pinching lifts that layer away from the muscle underneath, reducing the risk of an intramuscular injection. Whether you pinch depends on your body composition and which site you are using. The NHS semaglutide medicines page advises following the full instructions in your Patient Information Leaflet, and your prescriber can walk you through technique at any point. These are prescription-only medicines requiring a clinical assessment before they can be supplied.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you pinch a fold of skin between your thumb and forefinger, you pull the subcutaneous fat layer away from the muscle below it. Subcutaneous fat is exactly where a Wegovy injection is supposed to land. If there is not much of a fat cushion at the site you have chosen, the needle can pass straight through and deposit semaglutide into the muscle instead. That is not dangerous in a dramatic sense, but it can cause more discomfort at the site, and muscular tissue absorbs medicines differently to fat, which is not what the medicine is designed for.
The Wegovy pen uses a fine, short needle (typically 4 mm) that is sized precisely to reach the subcutaneous layer in most adults without any particular technique adjustment. For people with more subcutaneous tissue, especially at the abdomen, a pinch may be entirely unnecessary. For people with less fat at the thigh or upper arm, it becomes a straightforward safeguard. The instruction is not a rigid rule for everyone; it is a contingency that protects the injection landing in the right layer.
If you are uncertain how much tissue you have at your preferred site, the practical test is simple: pinch and see how much you can hold. A reasonable fold of soft tissue means you have enough to inject into. A thin, firm fold that feels more like skin alone is a sign to try a different site or to use the pinch technique.
Wegovy can be injected into the abdomen (at least 5 cm from the navel), the front of the thigh, or the outer upper arm. Each site has a different typical fat distribution, and that affects whether pinching helps.
The abdomen is usually the site where people have the most subcutaneous fat, so pinching is less often necessary there, especially earlier in treatment before significant weight loss occurs. The thigh is more variable; the front of the thigh tends to have a modest fat layer, and many patients find a pinch helpful here. The upper arm is often the site with the least accessible fat, and it is also the trickiest to self-inject into correctly — some people manage it fine, but the arm is more commonly used when someone else is doing the injection.
Rotation across sites matters too. Using the same small patch of skin repeatedly can lead to lipohypertrophy, a hardened, lumpy change in the tissue that can slow absorption. Rotating between and within sites, as NHS England's guidance on weight-management injections recommends, keeps the tissue healthy and keeps absorption consistent.
If you are thinking about switching between different treatment options, the Wegovy comparisons section covers how semaglutide sits alongside other approaches.
It can, and this is something people rarely think about at the start. Wegovy is a medicine that works over months. As weight reduces, subcutaneous fat at injection sites may reduce too, which means a site that felt comfortable and needed no pinch in the first few months might benefit from one later on. Staying aware of how each site feels over time is good habit.
There is a practical British parallel here: many patients end up adjusting their technique around month four or five, often around the same time they have noticed their clothes fitting differently. The site that used to need no thought may now need a little more attention. That is not a problem, it just means the medicine is doing its job, and technique should keep pace.
If you are injecting into the upper arm and reaching round is difficult, it is worth asking a partner or family member to help, or discussing alternative sites with your prescriber. Struggling with the injection at each weekly dose is not something to push through in silence.
If you are new to Wegovy or weighing it against other options, a clear overview of the medicine is on the Wegovy treatment page, and a broader look at how different weight-loss medicines compare is available on the weight-loss treatments overview.
Pinching is one part of a short but important checklist. Before each weekly dose, it is worth confirming: the pen has been at room temperature for about 30 minutes (cold medicine from the fridge can sting more); the injection site is clean and dry; you are not injecting into an area that is bruised, red, broken, or has a scar; and you hold the pen in place for the full count recommended in the leaflet after pressing the button, so the full dose is delivered.
Speed of injection matters less than depth and dwell time. Pulling the pen away too quickly before the dose has finished is a common reason for incomplete dosing. The click at the end of the injection signals the pen has fired, but the medicine still needs a moment to clear the needle tip into the tissue.
The Patient Information Leaflet that comes with your Wegovy pen contains step-by-step instructions with diagrams; those are the definitive guide for your specific pen. If you have questions about your individual circumstances (body composition, a site that is not healing well, or technique uncertainty after a dose increase) your prescriber is the right person to ask. Our clinical team is available for aftercare seven days a week. Questions about cost, what is included, and how private treatment is priced can be found on the Wegovy prices page. And if you are considering whether Wegovy is the right choice compared with other medicines, you can read what other patients have said in their Wegovy reviews, explore whether switching to Wegovy is the right next step before your consultation, or find out whether you can switch from Ozempic to Wegovy for weight loss if you are already on semaglutide treatment.
When you are ready to speak to a prescriber, you can start a free consultation and have your questions answered as part of the clinical review process.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.